Switzerland

Liom extends Series A with €13.9M to advance Non-Invasive Glucose Monitoring
Liom, a Swiss HealthTech company based in Schwyz, has secured an additional €13.9 million (CHF 13 million) as an extension to its Series A funding round.

The best Articles in our Network